Cardinal Health CAH Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Cost of product sold | $12.79B-0.1% | $12.8B+0.8% | $12.7B+0.5% | $12.64B+0.7% | $12.55B+0.4% | |
| Other Segments | $6.68B+6.4% | $6.28B+7.6% | $5.84B+8.5% | $5.38B+8.8% | $4.95B+3.1% | |
| Pharmaceutical and Specialty Solutions | $231.36B+2.5% | $225.68B+4.5% | $215.86B+5.5% | $204.64B-0.1% | $204.88B-0.1% | |
| Total Assets by Business | ||||||
| Cost of product sold | $27.9B-1.1% | $28.22B-0.2% | $28.28B-0.1% | $28.29B-0.6% | $28.45B-0.5% | |
| Other Segments | $16.23B+9.0% | $14.89B+10.0% | $13.54B+11.9% | $12.1B+13.5% | $10.66B+0.3% | |
| Pharmaceutical and Specialty Solutions | $160.43B+3.4% | $155.14B+7.8% | $143.86B+7.0% | $134.39B+6.5% | $126.22B+4.3% | |
| Total operating earnings by Business | ||||||
| Cost of product sold | $178M-7.3% | $192M+11.0% | $173M+28.1% | $135M+20.5% | $112M+17.9% | |
| Other Segments | $684M+7.0% | $639M+10.6% | $578M+12.0% | $516M+10.5% | $467M+5.4% | |
| Pharmaceutical and Specialty Solutions | $2.67B+4.8% | $2.55B+6.5% | $2.4B+6.1% | $2.26B+2.4% | $2.21B+3.8% | |
| Costs and Expenses by Business | ||||||
| Cost of product sold | $12.61B0.0% | $12.61B+0.7% | $12.52B+0.2% | $12.5B+0.5% | $12.44B+0.4% | |
| Other Segments | $6B+6.3% | $5.64B+7.2% | $5.26B+8.1% | $4.87B+9.6% | $4.44B+3.4% | |
| Pharmaceutical and Specialty Solutions | $228.68B+2.5% | $223.13B+4.5% | $213.46B+5.5% | $202.39B+1.4% | $199.55B-1.1% | |
| Cost of products sold by Business | ||||||
| Cost of product sold | $10.57B-0.3% | $10.6B+0.9% | $10.5B+0.3% | $10.47B+0.4% | $10.43B+0.7% | |
| Other Segments | $4.98B+6.3% | $4.68B+7.4% | $4.36B+8.4% | $4.02B+9.6% | $3.67B+3.8% | |
| Pharmaceutical and Specialty Solutions | $225.87B+2.5% | $220.44B+4.5% | $210.95B+5.5% | $200B+1.4% | $197.29B-1.2% | |
| Segment Reporting, Long-Lived Asset, Expenditure for Addition by Business | ||||||
| Cost of product sold | $135M+3.1% | $131M+1.6% | $129M-3.0% | $133M+25.5% | $106M-5.4% | |
| Other Segments | $99M+7.6% | $92M+1.1% | $91M+3.4% | $88M+21.8% | $72.25M-3.0% | |
| Pharmaceutical and Specialty Solutions | $154M+2.7% | $150M+7.9% | $139M+17.8% | $118M+57.3% | $75M+23.0% | |
| D&A by Business | ||||||
| Cost of product sold | $211M-0.9% | $213M-2.3% | $218M+2.8% | $212M-2.0% | $216.25M+2.2% | |
| Other Segments | $85M-5.6% | $90M-10.0% | $100M+12.4% | $89M-18.2% | $108.75M+11.5% | |
| Pharmaceutical and Specialty Solutions | $263M+11.0% | $237M+8.2% | $219M+18.4% | $185M+13.5% | $163M-1.2% | |
| Goodwill by Business | ||||||
| Cost of product sold | $0— | $0— | $0— | $0— | $0— | |
| Other Segments | $6.99B+9.0% | $6.41B+9.9% | $5.83B+10.9% | $5.26B+12.4% | $4.68B0.0% | |
| Pharmaceutical and Specialty Solutions | $35.44B+5.8% | $33.51B+19.8% | $27.96B+18.7% | $23.55B+22.9% | $19.16B+27.4% | |
| Distribution, selling, general and administrative expenses by Business | ||||||
| Cost of product sold | $2.05B+1.5% | $2.02B-0.5% | $2.03B-0.3% | $2.03B+0.7% | $2.02B-0.9% | |
| Other Segments | $1.02B+6.7% | $957M+6.5% | $899M+6.6% | $843M+9.6% | $769.5M+1.9% | |
| Pharmaceutical and Specialty Solutions | $2.82B+4.8% | $2.69B+6.8% | $2.52B+5.4% | $2.39B+5.7% | $2.26B+3.2% | |
| Goodwill, Acquired During Period by Business | ||||||
| Cost of product sold | $0— | $0— | $0— | $0+100% | -$750K+50.0% | |
| Other Segments | $577M-0.2% | $578M+0.5% | $575M-0.5% | $578M— | $0— | |
| Revenue by Geography | ||||||
| Non-US | $1.71B+1.4% | $1.69B+0.4% | $1.68B+0.7% | $1.67B-0.4% | $1.68B-1.5% | |
| UNITED STATES | $249.12B+2.5% | $243.07B+4.5% | $232.71B+5.3% | $220.99B+0.1% | $220.7B0.0% | |
| PP&E (Net) by Geography | ||||||
| Non-US | $1.74B— | —— | —— | —— | —— | |
| UNITED STATES | $9.76B— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cardinal Health break its business down?
- Cardinal Health (CAH) reports revenue by business across 3 parts — Cost of product sold, Other Segments and Pharmaceutical and Specialty Solutions. Each is extracted from the segment footnotes and tracked over time.
- Where does Cardinal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cardinal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
